Worldwide Filgrastim Industry to 2027 - An Increase in the Aging Population is Driving Growth
21 janv. 2022 04h29 HE
|
Research and Markets
Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027"...
Global $880 Million Pegfilgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F
25 oct. 2021 04h18 HE
|
Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
Global $1.04 Bn Filgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F
20 oct. 2021 04h13 HE
|
Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Global Myelodysplastic Syndrome Treatment Drugs Market (2021 to 2029) - Featuring Bayer, Celgene and Incyte Among Others
17 juin 2021 07h58 HE
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome (MDS) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
Global Filgrastim Biosimilars Market Report 2020: Due to COVID-19, the Market is Expected to Decline from $511.15 Million in 2019 to $445.04 Million in 2020
03 févr. 2021 04h48 HE
|
Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Major...